Josiane E Eid Selected Research

SYT-SSX fusion protein

11/2013	Targeting the Wnt pathway in synovial sarcoma models.
5/2012	Genome-wide recruitment to Polycomb-modified chromatin and activity regulation of the synovial sarcoma oncogene SYT-SSX2.
1/2009	The synovial sarcoma-associated SYT-SSX2 oncogene antagonizes the polycomb complex protein Bmi1.
10/2007	The synovial sarcoma SYT-SSX2 oncogene remodels the cytoskeleton through activation of the ephrin pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Josiane E Eid Research Topics

Disease

7	Neoplasms (Cancer) 01/2022 - 10/2007
5	Synovial Sarcoma (Synovioma) 01/2021 - 10/2007
3	Sarcoma (Soft Tissue Sarcoma) 10/2017 - 11/2013
2	Chondrosarcoma 01/2022 - 01/2020
2	Carcinogenesis 01/2020 - 05/2012
1	Genetic Translocation (Chromosomal Translocation) 06/2015
1	Cysts 11/2008

Drug/Important Bio-Agent (IBA)

4	SYT-SSX fusion proteinIBA 11/2013 - 10/2007
3	Proteins (Proteins, Gene)FDA Link 06/2015 - 10/2007
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2020 - 10/2017
2	EnzymesIBA 01/2020 - 10/2017
2	ChromatinIBA 06/2015 - 05/2012
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2021
1	infigratinibIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	IntegrinsIBA 01/2020
1	DioxygenasesIBA 01/2020
1	LipidsIBA 10/2017
1	NucleotidesIBA 10/2017
1	Amino Acids FDA Link 10/2017
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 10/2017
1	Tricarboxylic AcidsIBA 10/2017
1	Transcription Factors (Transcription Factor)IBA 06/2015
1	Indicators and Reagents (Reagents)IBA 06/2015
1	CateninsIBA 11/2013
1	Oncogene Proteins (Oncogene Protein)IBA 11/2008
1	Adenosine Triphosphate (ATP)IBA 11/2008
1	CollagenIBA 11/2008
1	EphrinsIBA 10/2007
1	TubulinIBA 10/2007

Therapy/Procedure

4	Therapeutics 01/2022 - 11/2013